Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic cromolyn sodium

This article was originally published in The Tan Sheet

Executive Summary

Perrigo ANDA 75-427 for equivalent to Pharmacia's NasalCrom approved Dec. 12. Private labeler becomes second ANDA holder to receive FDA clearance to market cromolyn sodium nasal spray; Bausch & Lomb's application was approved in July (1"The Tan Sheet" July 9, In Brief)...

Perrigo ANDA 75-427 for equivalent to Pharmacia's NasalCrom approved Dec. 12. Private labeler becomes second ANDA holder to receive FDA clearance to market cromolyn sodium nasal spray; Bausch & Lomb's application was approved in July (1 (Also see "Generic cromolyn sodium" - Pink Sheet, 9 Jul, 2001.), In Brief)....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093398

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel